Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,216.20 +44.05 (+0.54%) Bitcoin USD
60,268.36 +1,510.97 (+2.57%) CMC Crypto 200
1,279.82 +2.84 (+0.22%)
ALX Oncology Holdings Inc. (ALXO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 16.94 |
| Open | 17.16 |
| Bid | 16.60 x 100 |
| Ask | 16.66 x 400 |
| Day's range | 16.53 - 17.39 |
| 52-week range | 3.94 - 17.47 |
| Volume | |
| Avg. volume | 494,825 |
| Market cap | 839.29M |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
Roche's (RHHBY) Columvi, in combination with GemOx, achieves the primary endpoint of overall survival in a late-stage lymphoma study.
- Zacks
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
ALX Oncology (ALXO) announces positive results from an early to mid-stage study of an investigational combination regimen to treat indolent and aggressive R/R B-NHL.
- GuruFocus.com
ALX Oncology Holdings Inc (ALXO) Insider Sells Shares
Jaume Pons, PRESIDENT & Chief Scientific Officer of ALX Oncology Holdings Inc (NASDAQ:ALXO), sold 20,000 shares of the company on April 4, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.